TY - JOUR
T1 - Low-level lead exposure triggers neuronal apoptosis in the developing mouse brain
AU - Dribben, William H.
AU - Creeley, Catherine E.
AU - Farber, Nuri
N1 - Funding Information:
This work was supported by NIH grants T32DA07261 (WHD), 1K08NS048113-01A2 (WHD), T32 MH14677 (CC), and P30HD062171 (NBF).
PY - 2011/7
Y1 - 2011/7
N2 - While the toxic effects of lead have been recognized for millennia, it has remained a significant public health concern due to its continued use and toxicological potential. Of particular interest is the increased susceptibility of young children to the toxic effects of lead. Although the exact mechanism(s) for lead toxicity is currently not well understood, research has established that it can be a potent NMDA antagonist. Previous research has established that exposure to NMDA antagonists during the brain growth spurt period (first 2. weeks of life in mice) can produce apoptotic neurodegeneration throughout the brain. Based on this information, the ability of lead exposure (two injections of 350. mg/kg lead 4. h apart) to produce apoptosis in the neonatal mouse brain was assessed histologically 8-24. h after treatment using activated caspase-3 immunohistochemistry, De Olmos silver technique, Nissl staining, and electron microscopy. Lead exposure produced significant neurodegeneration in the caudate/putamen, hippocampus, subiculum, and superficial and deep cortical layers of the frontal cortical regions. Further ultrastructural examination revealed cellular profiles consistent with apoptotic cell death. Statistical results showed that lead exposure significantly increased apoptotic neurodegeneration above that seen in normal controls in animals treated at postnatal day 7, but not on day 14. The results of this study may provide a basis for further elucidation of mechanisms through which the immature nervous system may be particularly susceptible to lead exposure.
AB - While the toxic effects of lead have been recognized for millennia, it has remained a significant public health concern due to its continued use and toxicological potential. Of particular interest is the increased susceptibility of young children to the toxic effects of lead. Although the exact mechanism(s) for lead toxicity is currently not well understood, research has established that it can be a potent NMDA antagonist. Previous research has established that exposure to NMDA antagonists during the brain growth spurt period (first 2. weeks of life in mice) can produce apoptotic neurodegeneration throughout the brain. Based on this information, the ability of lead exposure (two injections of 350. mg/kg lead 4. h apart) to produce apoptosis in the neonatal mouse brain was assessed histologically 8-24. h after treatment using activated caspase-3 immunohistochemistry, De Olmos silver technique, Nissl staining, and electron microscopy. Lead exposure produced significant neurodegeneration in the caudate/putamen, hippocampus, subiculum, and superficial and deep cortical layers of the frontal cortical regions. Further ultrastructural examination revealed cellular profiles consistent with apoptotic cell death. Statistical results showed that lead exposure significantly increased apoptotic neurodegeneration above that seen in normal controls in animals treated at postnatal day 7, but not on day 14. The results of this study may provide a basis for further elucidation of mechanisms through which the immature nervous system may be particularly susceptible to lead exposure.
KW - Apoptosis
KW - Lead
KW - NMDA antagonist
KW - Neurodevelopment
KW - Neurotoxicity
UR - http://www.scopus.com/inward/record.url?scp=79960629364&partnerID=8YFLogxK
U2 - 10.1016/j.ntt.2011.05.006
DO - 10.1016/j.ntt.2011.05.006
M3 - Article
C2 - 21640820
AN - SCOPUS:79960629364
SN - 0892-0362
VL - 33
SP - 473
EP - 480
JO - Neurotoxicology and Teratology
JF - Neurotoxicology and Teratology
IS - 4
ER -